603233.SH
大参林
SSE · Healthcare · Biotechnology · CN
CNY 17.36
−1.70%Aug 24, 2026, 09:31 UTC
Dashenlin's board proposed a cash dividend of 0.41 yuan per share (including tax) for the first half of 2026.
Source:Aug 24, 2026, 09:31 UTC
Dashenlin announced its first-half 2026 results: revenue of 13.991 billion yuan, up 3.46% year-on-year; net profit attributable to shareholders of 927 million yuan, up 16.10% year-on-year.
Source: